- Home
- CII vs IRMD Comparison
CII vs IRMD Comparison
Compare CII & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CII | IRMD |
|---|---|---|
| Founded | 2004 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CII | IRMD |
|---|---|---|
| Price | $23.69 | $87.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $118.00 |
| AVG Volume (30 Days) | 73.5K | ★ 102.7K |
| Earning Date | 01-01-0001 | 10-30-2026 |
| Dividend Yield | ★ 6.17% | 0.93% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $9.69 |
| Revenue Next Year | N/A | $11.28 |
| P/E Ratio | ★ N/A | $62.65 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $20.43 | $76.35 |
| 52 Week High | $26.17 | $107.90 |
Technical Indicators
Market Signals| Indicator | CII | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 53.60 |
| Support Level | $23.28 | $83.34 |
| Resistance Level | $25.15 | $89.20 |
| Average True Range (ATR) | 0.35 | 2.92 |
| MACD | 0.01 | 0.25 |
| Stochastic Oscillator | 82.86 | 82.45 |
Price Performance
Historical ComparisonAbout CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.